Genine Winslow

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA.

Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California.

Verana Health, Inc. engages in the development of software solutions for remote patient monitoring and data analytics. It focuses on bridging the gap between healthcare providers and patients with mobile tests. The company was founded by Mark S. Blumenkranz and Daniel V. Palanker in 2008 and is headquartered in San Francisco, CA.

ETHRIS GmbH is a German company that specializes in developing innovative therapies and vaccines using its proprietary messenger RNA technology platform. The company is based in Planegg, Germany. The company is a leader in delivering stabilized mRNA directly to the respiratory system via optimized formulation and nebulization technologies. ETHRIS is rapidly advancing its pipeline of immuno-modulation, protein replacement therapies, and differentiated vaccines, with the ultimate goal of improving patients' lives. The company was founded by Carsten Rudolph and Christian Plank, and Carsten Rudolph has been the CEO since incorporation.

Kryptos Biotechnologies, Inc engages in the development of life science tools that capture genuine status of each cell to present unbiased genomic characteristics. The company was founded by Jin Yong Lee and Jun Ho Son in 2017 and is headquartered in Hayward, CA.

SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company.

Inhalon Biopharma, Inc. operates as a biotechnology company. It develops an inhaled immunotherapy platform for treating acute respiratory infections. The company is headquartered in Carrboro, NC.

Saccharo, Inc. is a biotech startup located in Oakland, CA. The company is focused on developing products for a novel polysaccharide target found only on cancer cells, not on normal cells, which is constant across all stages and types of cancer. This target is involved in a unique immune shielding pathway and serves as a platform for multiple drug modalities. Sheryl Martin-Moe has been the CEO of the company since 2017.

Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA.